<< Back To Home

PrePex Male Circumcision: Follow-Up and Outcomes during the First Two Years of Implementation at the Rwanda Military Hospital

Saturday, 7th of November 2015 Print

PrePex Male Circumcision: Follow-Up and Outcomes during the First Two Years of Implementation at the Rwanda Military Hospital

Ndagijimana A1, Mugenzi P2, Thomson DR3, Hedt-Gauthier B3, Condo JU1, Ngoga E2.

  • 1University of Rwanda College of Medicine and Health Sciences School of Public Health, Kigali, Rwanda.
  • 2Rwanda Military Hospital, Kigali, Rwanda.
  • 3University of Rwanda College of Medicine and Health Sciences School of Public Health, Kigali, Rwanda; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, United States of America.

Abstract below; full text is at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138287

PLoS One. 2015 Sep 23;10(9):e0138287. doi: 10.1371/journal.pone.0138287. eCollection 2015.

BACKGROUND:

PrePex Male Circumcision (MC) has been demonstrated as an effective and scalable strategy to prevent HIV infection in low- and middle-income countries. This study describes the follow-up and outcomes of clients who underwent PrePex MC between January 2011 and December 2012 with weekly follow-up at the Rwanda Military Hospital, the first national hospital in Rwanda to adopt PrePex.

METHODS:

Data on570 clients age 21 to 54 were extracted from patient records. We compared socio-demographic and clinical characteristics, the operators qualification, HIV status, pain before and after device removal, urological status, device size and follow-up time between clients who were formally discharged and those who defaulted. We reported bivariate associations between each covariate and discharge status, number of people with adverse events by discharge status, and time to formal discharge or defaulting using life table methods. Data were entered into Epidata and analyzed with Stata v13.

RESULTS:

Among study participants, 96.5% were circumcised by non-physician operators, 85.4%were under 30years, 98.9% were HIV-negative and 97.9% were without any urological problems that could delay the healing time. Most (70.7%) defaulted before formal discharge. Pain before (p<0.001) and after PrePex device removal (p = 0.001) were associated with discharge status, although very few cases were reported, and pain was more commonly missing among defaulters. Twenty-seven adverse events were reported (7 formally discharged, 20 defaulters). Median follow-up time was seven weeks among formally discharged and six weeks among defaulters (p<0.001).

CONCLUSION:

Given that all socio-demographic and most clinical characteristics were not associated with defaulting, we hypothesize that clients stopped returning once they determined they were healed. We recommend less frequent follow-up protocols to encourage clinical visits until formal discharge. Based on these results and recommendations, we believe PrePex MC is a practical circumcision strategy in Rwanda and in sub-Saharan Africa.

Similar articles

 

41150271